Page 835 - First Aid for the USMLE Step 1 2020, Thirtieth edition [MedicalBooksVN.com]_Neat
P. 835

INDEX                                                                                        INDEX                     791




                  Proteus spp                  vancomycin for, 190      Pterygoid muscles, 507    Punishment, 554
                    struvite stones with, 127  watery diarrhea, 179     PTH-related peptide (PTHrP), 332  Pupil
                    urease-positive, 127     Pseudomembranous pharyngitis  PTHrP (parathyroid hormone-related   Argyll Robertson, 147
                    xanthogranulomatous        diphtheria, 139                protein), 228         CN III palsy, 541
                         pyelonephritis, 600  Pseudomonas spp           Ptosis                      control, 507, 539
                  Proteus mirabilis            aeruginosa, 143           CN III damage, 541         light reflex, 539
                    cephalosporins, 189        biofilm production, 128   Horner syndrome, 540       pupillary light reflex, 539
                    penicillins for, 188       ceftazidime, 189          myasthenia gravis, 472     syphilis, 147, 184
                    urinary tract infections, 181, 600  culture requirements for, 126  saccular aneurysm, 516  Pure motor stroke, 514
                  Prothrombin                  cystic fibrosis, 60, 179  Puberty                  Pure red cell aplasia, 228
                    complex concentrate transfusion,   encapsulated, 127  GnRH and, 328             thymoma and, 98
                         429                   epididymitis and orchitis, 654  Kallmann syndrome and, 639  Purines, 194
                    warfarin effect on, 436    exotoxin production, 132  precocious, 57, 335        de novo synthesis, 36, 73
                  Prothrombin gene mutation, 428  fluoroquinolones, 195  Tanner stages, 637         Lesch-Nyhan syndrome, 37
                  Prothrombin time, 390        immunodeficient patients, 118  Pubic tubercle, 370   salvage deficiencies, 37
                  Protofilament, 48            multidrug-resistant, 198  Public health sciences, 256–273  structure of, 35
                  Proton pump inhibitors, 254, 399  nosocomial infection, 179, 185  Pudendal nerve, 366, 453  Purkinje cells
                    Beers criteria, 247        osteomyelitis, 180       Pulmonary anthrax, 137      cerebellum, 499
                    for Helicobacter pylori, 146  penicillins for, 188  Pulmonary arterial hypertension   of cerebellum, 210
                    gastrin and, 371           pigment production, 128        (PAH), 679            in paraneoplastic cerebellar
                  Protozoa                     pyocyanin of, 109        Pulmonary artery, 619           degeneration, 228
                    CNS infections, 156        tricuspid valve endocarditis, 311  fetal circulation, 282  Purkinje fibers, 293
                    GI infections, 155         UTIs, 181                Pulmonary artery stenosis, 300  Purpura
                    hematologic infections, 157  Pseudo-Pelger-Huet anomaly, 432  Pulmonary capillary wedge pressure   aplastic anemia, 421
                    miscellaneous, 158       Pseudopseudohypoparathyroidism,   (PCWP), 297, 668   Pustular psoriasis, 475
                    watery diarrhea, 179           344                  Pulmonary circulation, 668  Pustules, 475
                  Proximal convoluted tubules    Pseudotumor cerebri, 521  Pulmonary edema, 309     acne, 477
                         (PCT)                 drug reactions and, 251   consolidation in, 680      pseudofolliculitis barbae, 477
                    in ATN, 602                vitamin A toxicity, 66    LV failure, 307            rosacea, 477
                    defects in, 586          Pseudovirion, 162           mannitol, 607            Putamen, 500
                    diuretics and, 609       Psittacosis, 149            nitrates for, 318          neurodegenerative disorders, 520
                    dopamine secretion by, 589  Psoriasis, 477           opioids for, 551         Pyelonephritis, 600
                    glucose clearance and, 584  arthritis and, 469       preeclampsia and, 643      kidney stones, 598
                    ischemia susceptibility, 210  cyclosporine, 120     Pulmonary embolism, 672     urinary tract infections, 181, 600
                    relative concentrations in, 587  etanercept for, 487  chronic thromboembolism, 679  WBC casts in, 594
                    renal cell carcinoma and, 605  hyperkeratosis/parakeratosis, 475  direct factor Xa inhibitors for,    Pygmalion effect, 260
                  Proximal interphalangeal (PIP) joints,   infliximab/adalimumab for, 487  437    Pyloric sphincter, 373
                         451                   methotrexate for, 440     heparin for, 436         Pyloric stenosis, 359
                  Proximal renal tubular acidosis   skin lesions, 475    tamoxifen/raloxifene and, 443  Pyloromyotomy, 359
                         (type 2), 593         therapeutic antibodies, 122  thrombolytics for, 437
                  PRPP (glutamine-phosphoribosyl-  Psoriatic arthritis, 469  ventilation/perfusion with, 669  Pyoderma gangrenosum
                         pyrophosphate)        HLA-B27 and, 100         Pulmonary fibrosis          inflammatory bowel disease, 382
                         amidotransferase, 73  leflunomide for, 486      amiodarone and, 323      Pyogenic granulomas, 478
                  Pruritus                     psoriasis and, 477        bleomycin, 439           Pyramidal cells, 210
                    anal, 159                Psychiatric emergencies     busulfan, 441            Pyramidalis muscle, 369
                    atopic dermatitis, 477     acute dystonia, 569       diffusion in, 668        Pyramidal tract demyelination,
                    biliary tract disease, 395  delirium tremens, 569    drug reaction and, 251         multiple sclerosis, 523
                    chloroquine, 200           hypertensive crisis, 569  methotrexate, 440        Pyrantel pamoate, 200
                    cutaneous mycoses, 152     lithium toxicity, 569     restrictive lung disease, 675  Pyrazinamide, 197
                    ectoparasites, 161         neuroleptic malignant syndrome,   Pulmonary hypertension, 679  gout, 250
                    histamine receptors and, 238   569                   cor pulmonale, 668         hepatitis, 249
                    hyperchylomicronemia, 94   serotonin syndrome, 569   drug therapy, 686          Mycobacterium tuberculosis, 196
                    lichen planus, 482         tricyclic antidepressant overdose,   Schistosoma, 160  Pyridostigmine, 240
                    pseudofolliculitis barbae, 477  569                 Pulmonary hypoplasia, 660   myasthenia gravis treatment, 472
                    urticaria, 477           Psychiatry, 554–576        Pulmonary infections      Pyridoxal phosphate, 67
                  Prussian blue stain, 677     pathology, 556–570        in immunocompromised patients,   Pyridoxine, 67
                  Psammoma bodies, 211, 227    pharmacology, 572–576          139                 Pyrimethamine, 200
                    mesotheliomas, 678         psychology, 554–555      Pulmonary Langerhans cell   effect on purine synthesis, 36
                    papillary thyroid carcinoma, 343  Psychoactive drug intoxication/  histiocytosis, 675  Pyrimidine dimers, 40
                  Pseudoappendicitis               withdrawal, 570–571  Pulmonary surfactant      Pyrimidines
                    Yersinia enterocolitica, 144  Psychological child abuse, 556  club cells, 660, 661  de novo synthesis, 36
                  Pseudocysts, 397           Psychology, 554–555         NRDS, 661                  structure of, 35
                  Pseudoephedrine, 686       Psychosis, 559             Pulmonary vascular resistance (PVR),   Pyrimidine synthesis, 486
                  Pseudofolliculitis barbae, 477  corticosteroids, 120        668                 Pyruvate carboxylase, 77, 78
                  Pseudofractures, 463         diabetic ketoacidosis, 347  Pulmonic stenosis        metabolic pathways, 74
                  Pseudoglandular stage        drug therapy for, 573     wide splitting in, 289     vitamin B  and, 68
                                                                                                          7
                         (development), 660    LSD and, 571             Pulmonic valves, 281      Pyruvate dehydrogenase
                  Pseudogout, 467              major depressive disorder with, 561  “Pulseless disease,” 314  complex, 76
                  Pseudohermaphrodites, 639    PCP and, 571             Pulse pressure              deficiency, 77
                  Pseudohypoparathyroidism, 344  postpartum, 562         equation for, 285          metabolic pathways, 74
                  Pseudomembranous colitis   Psychotherapy, 572         Pulsus paradoxus, 310       vitamin B  and, 66
                                                                                                          1
                    clindamycin, 192           oppositional defiant disorder, 557  croup, 170     Pyruvate kinase, 74
                    Clostridium difficile, 138  Psychotic disorders     “Punched out” bone lesions (X-ray),   deficiency, 422
                    drug reaction and, 249     readmissions with, 272         431                 Pyruvate metabolism, 77
                    penicillins, 188         PTEN gene, 224             Punched-out ulcers, 377   Pyuria, 601







          FAS1_2019_21_Index_749-806.indd   791                                                                        11/21/19   12:27 PM
   830   831   832   833   834   835   836   837   838   839   840